Furosemide and Skin hypertrophy - a phase IV clinical study of FDA data
Summary:
Skin hypertrophy is found among people who take Furosemide, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Furosemide and have Skin hypertrophy. It is created by eHealthMe based on reports of 274,621 people who have side effects when taking Furosemide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
274,621 people reported to have side effects when taking Furosemide.
Among them, 170 people (0.06%) have Skin hypertrophy.
What is Furosemide?
Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 276,826 Furosemide users for its effectiveness, alternative drugs and more.
What is Skin hypertrophy?
Skin hypertrophy (skin cells enlarges) is found to be associated with 1,050 drugs and 509 conditions by eHealthMe.
Number of Furosemide and Skin hypertrophy reports submitted per year:
Time on Furosemide when people have Skin hypertrophy *:
Gender of people who have Skin hypertrophy when taking Furosemide*:
Age of people who have Skin hypertrophy when taking Furosemide *:
Common drugs people take besides Furosemide *:
Common side effects people have besides Skin hypertrophy *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Furosemide and have Skin hypertrophy?
Check whether Skin hypertrophy is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
Related studies
How severe was Skin hypertrophy and when was it recovered:
Expand to all the drugs that have ingredients of furosemide:
Alternative drugs to, pros and cons of Furosemide:
- Furosemide (276,826 reports)
Common Furosemide side effects:
- Breathing difficulty: 19,316 reports
- Fatigue (feeling of tiredness): 14,970 reports
- Diarrhea: 13,530 reports
- Hypotension (abnormally low blood pressure): 13,476 reports
- Weakness: 13,137 reports
- Pneumonia: 13,078 reports
Browse all side effects of Furosemide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSkin hypertrophy treatments and more:
- Skin hypertrophy (3,618 reports)
COVID vaccines that are related to Skin hypertrophy:
- Skin hypertrophy in Moderna COVID Vaccine
- Skin hypertrophy in Pfizer BioNTech Covid Vaccine
- Skin hypertrophy in Johnson and Johnson Covid Vaccine
Common drugs associated with Skin hypertrophy:
- Magnevist: 1,066 reports
- Omniscan: 889 reports
- Optimark: 676 reports
- Multihance: 605 reports
- Prohance: 570 reports
- Renagel: 512 reports
- Prednisone: 462 reports
- Coumadin: 393 reports
- Aspirin: 364 reports
- Phoslo: 346 reports
All the drugs that are associated with Skin hypertrophy:
- Skin hypertrophy (1,050 drugs)
Common conditions associated with Skin hypertrophy:
- Arteriogram: 388 reports
- High blood pressure: 227 reports
- Pain: 175 reports
- Rheumatoid arthritis: 172 reports
- Diabetes: 111 reports
All the conditions that are associated with Skin hypertrophy:
- Skin hypertrophy (509 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on furosemide (the active ingredients of Furosemide) and Furosemide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lyrica and Dermatitis - Atopic - 3 seconds ago
- Lyrica and Eczema - 4 seconds ago
- Valium vs. Serzone - 6 seconds ago
- Isosorbide Dinitrate and Ischaemic Stroke - 8 seconds ago
- Septra vs. Levaquin - 8 seconds ago
- Phentermine and Toothaches - 8 seconds ago
- Xarelto and Splenomegaly - 11 seconds ago
- Seasonique vs. Estradiol - 11 seconds ago
- Levonorgestrel vs. Seasonale - 13 seconds ago
- Lynparza and Synthroid drug interaction - 15 seconds ago